Effects of Exercise Training on Mechanoreflex and Metaboreflex Control in Heart Failure Patients
1 other identifier
interventional
34
1 country
1
Brief Summary
The investigators hypothesize that exercise training would improve the mechanoreflex and metaboreflex control in heart failure patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Mar 2008
Longer than P75 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 27, 2013
CompletedFirst Posted
Study publicly available on registry
June 21, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedApril 28, 2021
April 1, 2021
4.8 years
March 27, 2013
April 26, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Autonomic Control
Mechanoreceptors were activated by passive exercise and metaboreceptors by post-exercise circulatory arrest
4 months
Muscular Evaluation
Muscular evaluation will be done by muscle gene expression
4 months
Secondary Outcomes (3)
Functional Capacity
4 months
Muscle Blood Flow
4 months
Blood Pressure
4 months
Study Arms (2)
Heart Failure Untrained Group
NO INTERVENTIONControl Group
Heart Failure Exercise-trained Group
EXPERIMENTALAerobic Exercise Training
Interventions
Eligibility Criteria
You may qualify if:
- Patients with systolic heart failure;
- New York Heart Association (NYHA) class II-III;
- Left ventricular ejection fraction less than 40%;
- Peak Oxygen Consumption less than 20 ml/Kg/min;
- Stable Clinical Status.
You may not qualify if:
- Chronic Obstructive Pulmonary Disease;
- Neuromuscular Diseases;
- Orthopedic Diseases;
- Neurologic Diseases;
- Neoplastic Diseases;
- Recent myocardial infarction or cardiac surgery (less than 6 months);
- Unstable angina pectoris;
- Atrial Fibrillation;
- Pacemakers users;
- Changing medication or hospital admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Heart Institute (InCor), University of Sao Paulo Medical School
São Paulo, 05403-904, Brazil
Related Publications (1)
Unable to connect to PubMed to validate , last attempt on June 19, 2013 at 12:03 PM EDT
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos E Negrão, PhD
University of Sao Paulo General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
March 27, 2013
First Posted
June 21, 2013
Study Start
March 1, 2008
Primary Completion
December 1, 2012
Study Completion
January 1, 2014
Last Updated
April 28, 2021
Record last verified: 2021-04